Why he matters in this case
Prof. Taylor’s signature, alongside Prof. Manzar’s, establishes that the Panel’s finding is endorsed by senior US neonatology from two institutions. Tulane University is a long-established American medical research centre; the Tulane neonatology programme is embedded in the US neonatal-intensive-care training pipeline and participates in multi-site clinical research networks.
Professional background
- Professor of Paediatrics, Tulane University.
- Peer-reviewed publication record in clinical neonatology.
- Member of the Shoo Lee International Expert Panel.
The two-US-institution structure
When a Panel reports a case-by-case finding, the number of distinct institutions endorsing it matters for how the finding should be weighed. Two separate US universities signing the same conclusion is structurally different from one American clinician signing it. Prof. Taylor at Tulane and Prof. Manzar at LSU, together, represent the US neonatology endorsement of the Panel’s reading.
The North American neonatology perspective
Dr Taylor is one of the US-based members of the Panel. His role on the Panel is to bring the US clinical-practice perspective on neonatal-intensive-care decision-making and the differential-diagnosis frameworks routinely applied to unexpected collapses in preterm infants. US neonatology has produced much of the canonical research on neonatal sepsis, necrotising enterocolitis, intraventricular haemorrhage, and the cardiovascular instability of prematurity — the differentials that recur across the Panel’s case-by-case findings.
Two US Panel signatories rather than one means the US neonatology profession is institutionally represented on the Panel rather than represented through a single individual. Dr Taylor’s sign-on alongside Dr Manzar establishes that the Panel finding is endorsed across more than one US neonatology institutional voice.
What US institutional representation contributes
The US neonatal-intensive-care system operates with substantially more subspecialist resources than the UK NHS Level 2 environment in which the Countess of Chester unit was operating in 2015-2016. Dr Taylor’s perspective contributes particularly to the Panel’s reading of deteriorations against the documented natural-cause distributions for very preterm infants. His sign-on adds the US-clinical-research evidence base to the Panel’s methodology.
Geographical coherence of the Panel finding
The Panel’s finding is unanimous across 14 senior neonatologists from eight countries on three continents. Dr Taylor’s sign-on is one of the North American institutional anchors of that unanimity. A finding that holds across this institutional and geographical breadth has particular weight for the CCRC review because it cannot be characterised as the view of one school of clinical practice or one country’s neonatology professional community.